FDA Authorizes Pharmacists to Prescribe Paxlovid
The FDA has granted state-licensed pharmacists the power to prescribe Paxlovid (nirmatrelvir and ritonavir) to eligible patients, with certain limitations.
The FDA has granted state-licensed pharmacists the power to prescribe Paxlovid (nirmatrelvir and ritonavir) to eligible patients, with certain limitations.
The GOLD 2022 report updates evidence for blood eosinophil counts as biomarker in subset of patients with COPD.
Medline has been selected as Dayton Children’s Hospital’s laboratory prime vendor, entering into a multi-year agreement.
On World No Tobacco Day, May 31, international lung health groups are raising concerns over Big Tobacco's impact on environmental health and ultimately lung health.
Vitalograph is celebrating 21 years of empowering respiratory research through clinical trials services, with international team members fundraising for local respiratory charities to mark the milestone.
Children age 5-through-11 are now authorized to receive the Pfizer COVID booster at least five months after completion of their primary two-dose series of the Pfizer vaccine.
Philips responds to reports of an increase in medical device reports related to the company's respiratory device recall.